| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Department of Neurology, Washington University School of Medicine, St. Louis, MO.
The neuroleptic malignant syndrome (NMS) of extrapyramidal signs and hyperthermia is an uncommon complication of therapy with the major tranquilizers. Other manifestations are pallor, diaphoresis, blood pressure fluctuation, tachycardia, and tachypneic hypoventilation, which may necessitate respirator support. Death often occurs, but full recovery can result with prompt recognition and proper management. In a patient with Parkinson disease and a chronic psychiatric disorder treated with haloperidol, typical features of NMS appeared upon cessation of dopaminergic antiparkinsonian drugs. Manifestations of NMS are attributed to dopamine receptor blockade in the striatum, increasing thermogenesis, and in the hypothalamus, impairing heat dissipation.
Address correspondence and reprint requests to Dr. Henderson, Aphasia/Neurobehavioral Unit, Veterans Administration Hospital, 150 South Huntington Avenue, Boston, MA 02130.
Dr. Wooten is supported by a George C. Cotzias Fellowship from the American Parkinson's Disease Association.
Accepted for publication May 5, 1980
This article has been cited by other articles:
|
|
 |
|
  P. R. Karre, J. Gujral, and E. Rodriguez Rhabdomyolysis with erratic serum creatinin phosphokinase levels: intramuscular injection of haloperidol decanoate BMJ Case Reports, August 17, 2009; 2009(aug17_1): bcr0620091931 - bcr0620091931. [Abstract] [Full Text]
|
|
|
|
 |
|
 T. P. Bleck Seizures, Stroke, and Other Neurologic Emergencies ACCP Crit Care Med Brd Rev, January 1, 2009; 20(0): 433 - 466. [Full Text] [PDF]
|
|
|
|
 |
|
 G. J. Chandran, J. R. Mikler, and D. L. Keegan Neuroleptic malignant syndrome: case report and discussion Can. Med. Assoc. J., September 2, 2003; 169(5): 439 - 442. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Ueda, M Hamamoto, H Nagayama, S Okubo, S Amemiya, and Y Katayama Biochemical alterations during medication withdrawal in Parkinson's disease with and without neuroleptic malignant-like syndrome J. Neurol. Neurosurg. Psychiatry, July 1, 2001; 71(1): 111 - 113. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. Turner and N. Gainsborough Neuroleptic malignant-like syndrome after abrupt withdrawal of baclofen J Psychopharmacol, January 1, 2001; 15(1): 61 - 63. [Abstract] [PDF]
|
|
|
|
 |
|
 P. Adnet, P. Lestavel, and R. Krivosic-Horber Neuroleptic malignant syndrome Br. J. Anaesth., July 1, 2000; 85(1): 129 - 135. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Ueda, M. Hamamoto, H. Nagayama, K. Otsubo, C. Nito, T. Miyazaki, A. Terashi, and Y. Katayama Susceptibility to neuroleptic malignant syndrome in Parkinson's disease Neurology, March 1, 1999; 52(4): 777 - 777. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Gurrera Sympathoadrenal Hyperactivity and the Etiology of Neuroleptic Malignant Syndrome Am J Psychiatry, February 1, 1999; 156(2): 169 - 180. [Abstract] [Full Text]
|
|
|
|
 |
|
 D. L. Keyser and R. L. Rodnitzky Neuroleptic Malignant Syndrome in Parkinson's Disease After Withdrawal or Alteration of Dopaminergic Therapy Arch Intern Med, April 1, 1991; 151(4): 794 - 796. [Abstract] [PDF]
|
|
|
|
 |
|
 R. C. Boorse and M. Rhodes Neuroleptic Malignant Syndrome in a Multiple Trauma Patient Arch Surg, February 1, 1990; 125(2): 274 - 275. [Abstract] [PDF]
|
|
|
|
|
|
M. R. Rosenberg and M. Green Neuroleptic Malignant Syndrome: Review of Response to Therapy Arch Intern Med, September 1, 1989; 149(9): 1927 - 1931. [Abstract] [PDF]
|
|
|
|
 |
|
 W. T. Talman, G. Florek, and D. E. Bullard A Hyperthermic Syndrome in Two Subjects With Acute Hydrocephalus Arch Neurol, September 1, 1988; 45(9): 1037 - 1040. [Abstract] [PDF]
|
|
|
|
 |
|
 D. F. Levinson and G. M. Simpson Neuroleptic-Induced Extrapyramidal Symptoms With Fever: Heterogeneity of the 'Neuroleptic Malignant Syndrome' Arch Gen Psychiatry, September 1, 1986; 43(9): 839 - 848. [Abstract] [PDF]
|
|
|
|
 |
|
 F. J. Curley and R. S. Irwin Disorders of Temperature Control: Hyperthermia, Part II J Intensive Care Med, March 1, 1986; 1(2): 91 - 100. [Abstract] [PDF]
|
|
|
|
 |
|
 R. F. Kaplan, N. G. Feinglass, W. Webster, and S. Mudra Phenelzine Overdose Treated With Dantrolene Sodium JAMA, February 7, 1986; 255(5): 642 - 644. [Abstract] [PDF]
|
|
|
|
|
|
F. J. Curley and R. S. Irwin Analytic Review: Disorders of Temperature Control: Part I. Hyperthermia J Intensive Care Med, January 1, 1986; 1(1): 5 - 14. [Abstract] [PDF]
|
|
|
|
|
|
J. H. Friedman, S. S. Feinberg, and R. G. Feldman A Neuroleptic Malignantlike Syndrome due to Levodopa Therapy Withdrawal JAMA, November 15, 1985; 254(19): 2792 - 2795. [Abstract] [PDF]
|
|
|
|
|
|
R. T. Wang, D. E. Aftergood, and H. E. Carlson Hypercalcemia in the Neuroleptic Malignant Syndrome Arch Intern Med, January 1, 1985; 145(1): 143 - 144. [Abstract] [PDF]
|
|
|
|
|
|
G. R. Eles, J. E. Songer, and D. J. DiPette Neuroleptic Malignant Syndrome Complicated by Disseminated Intravascular Coagulation Arch Intern Med, June 1, 1984; 144(6): 1296 - 1297. [Abstract] [PDF]
|
|
|
|
|
|
F. Hashimoto, C. B. Sherman, and W. H. Jeffery Neuroleptic Malignant Syndrome and Dopaminergic Blockade Arch Intern Med, March 1, 1984; 144(3): 629 - 630. [Abstract] [PDF]
|
|
|
|
|
|
S. Dhib-Jalbut, R. Hesselbrock, and T. Brott Treatment of the Neuroleptic Malignant Syndrome With Bromocriptine JAMA, July 22, 1983; 250(4): 484 - 485. [Abstract] [PDF]
|
|
|
|
|
|
C. B. Sherman, F. Hashimoto, and E. J. Davidson Gas-Producing Escherichia coli Fasciitis in a Patient With the Neuroleptic Malignant Syndrome JAMA, July 15, 1983; 250(3): 361 - 361. [Abstract] [PDF]
|
|
|
|
|
|
P. S. Mueller, J. W. Vester, and J. Fermaglich Neuroleptic Malignant Syndrome: Successful Treatment With Bromocriptine JAMA, January 21, 1983; 249(3): 386 - 388. [Abstract] [PDF]
|
|
|
|
|
|
R. A. Smego Jr and D. T. Durack The Neuroleptic Malignant Syndrome Arch Intern Med, June 1, 1982; 142(6): 1183 - 1185. [Abstract] [PDF]
|
|
|
|
|
|
A. R. Eiser, M. S. Neff, and R. F. Slifkin Acute Myoglobinuric Renal Failure: A Consequence of the Neuroleptic Malignant Syndrome Arch Intern Med, March 1, 1982; 142(3): 601 - 603. [Abstract] [PDF]
|
|
|
|
 |
|
 J. JANKOVIC Drug-Induced and Other Orofacial-Cervical Dyskinesias Ann Intern Med, June 1, 1981; 94(6): 788 - 793. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
